Article

Comprehensive suppression of the renin–angiotensin–aldosterone system in chronic kidney disease: Covering all of the bases

Department of Medicine, Indiana University Medical Center, Indianapolis, Indiana 46202, USA.
Kidney International (Impact Factor: 8.52). 01/2007; 70(12):2051-3. DOI: 10.1038/sj.ki.5002007
Source: PubMed

ABSTRACT Reducing proteinuria and blood pressure in chronic kidney disease (CKD) decreases rate of progression. Inhibition of the renin-angiotensin system by angiotensin-converting enzyme inhibitors and/or angiotensin receptor blockers is beneficial in reducing proteinuria but incomplete in suppressing aldosterone production and its renal effects. Adding aldosterone receptor blockers to these other agents may further halt the progression of CKD.

Download full-text

Full-text

Available from: Myron H Weinberger, Aug 14, 2014
0 Followers
 · 
140 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Recent advances have identified the podocyte as a key target in glomerular injury. The podocyte is a highly specialized cell which is responsible for the glomerular permselectivity for proteins in the kidney. Podocyte injury or loss leads to proteinuria. Apoptosis has been shown to contribute to renal cell loss, including loss of podocytes. The most striking feature of the podocyte is its ability to form intricate specialized cell junctions, the slit diaphragm. Slit diaphragm proteins play an important role in podocyte biology, protein permselectivity, cell signalling and disease. This review focuses on recent advances on the understanding of podocyte survival regulation, its relationship to slit diaphragm structure and function, and how this knowledge may affect our therapeutic approach to proteinuric kidney disease.
    Current Medicinal Chemistry 02/2008; 15(16):1645-54. DOI:10.2174/092986708784911542 · 3.72 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Inflammation is a complex process that reflects the local and systemic responses to different immunological and non-immunological stimuli, enable resistance to disease, repair of tissue damage, and restoration of normal function with the least possible tissue damage. This is achieved by intact regulatory immune system, which includes pro- and anti-inflammatory cytokines, chemokines, growth factors, complement cascade system, renin-angiotensin system, and different sets of adhesion molecules expressed on leukocytes and vascular endothelium, in addition to neutrophils, monocytes/macrophages, and different subsets of T-lymphocytes. Once imbalance occurs in the different factors of the inflammatory response to injurious stimuli, inflammation will proceed and exacerbate tissue damage. Inflammation can be initiated by different stimuli such as deposition or formation of antibody-antigen immune complexes, sensitized T-cells, trauma, tissue necrosis, or infection. It is characterized by activation of acute phase response and release of reactants/markers such as C-reactive protein. Renal inflammation can occur either as an isolated local acute inflammatory reaction or as part of a systemic inflammatory disorder. Recently, there have been tremendous advancements in the fields of immunology and molecular biology that helped in exploring the mechanisms of renal inflammation. This has been accompanied by extensive in vitro and in vivo studies that led to a better understanding of phenotypic changes and multifunctional potentials of local and infiltrating cells, role and control of different inflammatory mediators, adhesion molecules, and the rennin-angiotensin system within the site of inflammation. These achievements helped in researching into ways to modulate renal inflammation, control the severity of renal injury, promote regeneration and tissue repair, and induce tolerance.
    Saudi journal of kidney diseases and transplantation: an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia 02/2008; 19(1):1-19.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Uso de antagonistas de aldosterona para detener la progresión de la enfermedad renal: de las bases fi siológicas a la aplicación clínica Sistema renina-angiotensina-aldosterona; Eplerenona; Espironolactona; Receptor de mineralocorticoides; Progresión de daño renal; Nefropatía crónica Resumen La aldosterona, sintetizada en la zona glomerulosa de la corteza suprarrenal, es la principal hormona reguladora del metabolismo de sodio y potasio y del volumen extracelular. A través del receptor de mineralocorticoides, actúa como la señal endocrina fi nal del sistema renina-angiotensina-aldosterona sobre el epitelio del túbulo renal y del colon distal, que estimu-la la reabsorción de sodio y la secreción de potasio. El agua se reabsorbe, vía ósmosis, favore-ciendo la expansión del volumen circulante y, por ende, incrementando la presión arterial. Recientemente, se ha centrado el interés en las acciones no clásicas de la aldosterona sobre el endotelio vascular, corazón y riñón. Existe evidencia de que la aldosterona está involucrada en la remodelación vascular, la función endotelial y la formación de colágena, y que contribuye a la progresión de la insufi ciencia cardiaca, así como del daño renal. Se revisa la evidencia clínica y experimental que fundamenta el uso de bloqueadores de aldosterona para detener la progresión del daño renal en diferentes modelos. © 2013 Hospital Infantil de México Federico Gómez. Publicado por Masson Doyma México S.A. Todos los derechos reservados. Documento descargado de http://zl.elsevier.es el 20/08/2014. Copia para uso personal, se prohíbe la transmisión de este documento por cualquier medio o formato. 138 M. Medeiros et al.